You are here: vision-research.eu » Vision Research » Vacancies

11/29/18

14 PhD positions at ITN StarT

14 PhD positions are available in the framework of the Marie Skłodowska-Curie Innovative Training Network (ITN) on

Training researchers to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder (StarT)

The objectives of StarT are twofold: 1) to give the next generation of European vision researchers unparalleled opportunities to be trained by a consortium of European vision research groups excelling in genomics, transcriptomics, functional genomics, bio-informatics, genome editing, stem cell biology, animal disease models, and therapy development; and 2) to address the knowledge gaps to diagnosing, understanding and treating STGD1 using innovative approaches related to the aforementioned disciplines.

Positions are available at:

  1. Ghent University, Belgium (https://www.ugent.be/en; https://www.debaerelab.com​)
  2. Radboud University Medical Center Nijmegen, The Netherlands (www.ru.nl/donders/research/theme-2-perception-action-control/research-groups-theme-2/blindness-genetics/;www.ru.nl/donders/research/theme-2-perception-action-control/research-groups-theme-2/genetic-therapy-inherited-retinal-disease/)
  3. Eberhard Karls University Tubingen, Germany (http://www.eye-tuebingen.de/wissingerlab/ )
  4. Telethon Institute of Genetics and Medicine, Naples, Italy (www.telethon.it; www.tigem.it)
  5. University of Leeds, United Kingdom (medhealth.leeds.ac.uk/info/311/ophthalmology_and_neuroscience)
  6. Spanish National Research Council, Seville, Spain (www.csic.eswww.upo.es/CABD/GomezSkarmetaLab)
  7. Trinity College Dublin, Ireland (www.tcd.ie)
  8. University College London, United Kingdom (https://www.ucl.ac.uk/)
  9. NewCells Biotech Ltd, Newcastle, United Kingdom (https://newcellsbiotech.co.uk/)
  10. ProQR Therapeutics, Leiden, The Netherlands (http://www.proqr.com/)

The StarT partners offer:

  • 14 PhD positions for a period of three years (fellowships for Early Stage Researchers / ESR),
    start date April 1, 2019. See the description of the individual ESR projects (PDF).

Eligibility criteria:

  • Applicants should be in the first 4 years (full-time equivalent) of their research careers, including the period of research training, starting at the date of obtaining the degree which would formally entitle them to embark on a doctorate.
  • Applicants should not have resided or performed their main activity in the country of the host institution for more than 12 months in the 3 year period immediately prior to the start date of the fellowship.

How to apply:

Applicants should submit 

  • personal statement explaining their motivation and project interests and the contact details of 2 academic referees
  • CV (EU format, MS Word, doc); other formats are NOT accepted
  • form indicating the preference for one or more specific partner institute(s) and/or research project(s) (use preference form, MS Word, doc)

Please send these documents via email to simone.dusseljee[at]radboudumc.nl

Applicants interested in the position at UCL should also apply via the UCL online recruitment tool (http://www.ucl.ac.uk/hr/jobs)

Deadline:

  • December 10, 2018, after which we will review applications and interview candidates.
  • Do NOT include other documents like diplomas.
  • PLEASE NOTE that applications that do not meet these requirements WILL NOT BE CONSIDERED.

More information

For more information on the application process and to download documents, please visit www.startn.eu or email simone.dusseljee[at]radboudumc.nl

To top

11/21/18

Postdoctoral positions at the Albert Einstein College of Medicine, Bronx, NY, USA

Postdoctoral positions are available at the Departments of Ophthalmology and Visual Sciences and Genetics, Albert Einstein College of Medicine, to study transcription, mRNA cycle, enhancer function, nuclear architecture, and signaling. The laboratory is studying general regulatory mechanisms of gene expression during eye development and disease using mouse models and human lens-retinal organoids. State-of-art methods, including but not limited to CRISPR-Cas9 genome engineering, single cell RNA-seq, RNA FISH and high-resolution microscopy, and isolation of novel RNA-binding proteins, are being used.

Interested candidates must be highly motivated and hold a PhD or MD degree. Experience in molecular and cell biology, gene expression studies, proteomic, signaling and use of embryonic stem cells, is desired. Interested individuals should send their Curriculum Vitae, and the contact information of three references to:

Dr. Ales Cvekl
Depts. of Ophthalmology and Visual Sciences and Genetics
Albert Einstein College of Medicine
123 Ullmann, 1300 Morris Park Avenue,
Jack and Pearl Resnick Campus,
Bronx, NY 10461

E-mail: ales.cvekl[at]einstein.yu.edu

To top

07/20/18

PhD position: Calcium channels in congenital stationary night blindness

Photoreceptors are morphologically and physiological highly specialised light sensing cells of the retina where sustained release of glutamate from ribbon synapses is calcium dependent and L-type calcium channels (LTCC) serve as the predominant source for Ca2+ entry. Mutations in the CACNA1F gene encoding Cav1.4 LTCCs were identified among patients diagnosed with congenital night blindness type 2 (OMIM: 30071). Ongoing work investigates the important role of Cav1.4 channels as calcium source for neurotransmitter release and stabilizers of the retinal synapse. The aim of this PhD project is to test the pharmaco-therapeutic potential of retinal LTCCs using gene therapy.

Methods: Retinal morphology and synapse structure (high-resolution fluorescent and electron microscopy; dye filling); functional analyses in retinal whole-mounts and slices (patch-clamp, slice electrophysiology; multielectrode array analyses); cell culture; retinal AAV gene-therapy.

References: Knoflach et al. (2015) Channels (Austin) 9(5):298-306; Bacchi et al. (2015) IOVS 56(8):4846-56.; Seitter and Koschak (2018) Neuropharmacology 132:58-70. (Review); Pangrsic et al. (2018) Physiol Reviews (Review).

Salary: According to the rates of the Austrian Science Fund (FWF) for PhD students plus travel funds for international scientific meetings.

Contact: Ao. Univ. Prof. Alexandra Koschak, University of Innsbruck, Institute of Pharmacy, Pharmacology and Toxicology, Innrain 80/82, 6020 Innsbruck, Austria
E-mail: alexandra.koschak[at]uibk.ac.at

Deadline for application: September 10, 2018

More information and application: The successful candidate will be part of the Neuroscience PhD program CavX-Calcium channels in excitable cells:

To top

Further Vacancies

If you have an open position and would like it to be presented on vision-research.eu - please send us the details

Please note: All information provided are supplied without any liability!